期刊文献+

吉西他滨对胰腺癌Patu 8988细胞摄取^(18)F-氟代脱氧葡萄糖的影响 被引量:2

Effect of Gemcitabine in the Uptake of ^(18)F-Fluorodeoxyglucose on Human Pancreatic Carcinoma Cell Patu 8988
原文传递
导出
摘要 目的研究测定胰腺癌Patu8988细胞的18F-氟代脱氧葡萄糖(FDG)细胞结合率方法和吉西他滨化疗后对胰腺癌Patu8988细胞摄取18F-FDG的影响。方法在不同条件下测定胰腺癌Patu8988细胞的18F-FDG细胞结合率,细胞数量为5×104~1×107/瓶,18F-FDG放射性活度为1.85~29.6kBq,反应时间为20~120min,葡萄糖浓度为0~11.1mmol/L。采用四甲基偶氮唑盐(MTT)法测定加入不同剂量(0~6mmol/L)吉西他滨10μl24h后细胞抑制率。测定加入不同剂量(0~60mmol/L)吉西他滨100μl24h后18F-FDG细胞结合率。结果当每瓶1×106个细胞、加入3.7kBq18F-FDG、葡萄糖浓度为5.55mmol/L、作用100min时,细胞结合率可达到(60.60±3.05)%。加入0、5、20、40和60mmol/L吉西他滨24h后,细胞结合率分别为(58.35±2.19)%、(56.34±1.56)%、(48.92±5.91)%、(39.14±7.40)%、(29.67±4.41)%。细胞结合率随吉西他滨剂量增加而下降,两者成负相关(r=-0.928,P<0.01)。给吉西他滨24h后,MTT实验抑制率与细胞结合抑制率成正相关(r=0.856,P<0.01)。结论吉西他滨作用24h后引起胰腺癌Patu898818F-FDG细胞结合率下降,有望用18F-FDG显像早期观测吉西他滨对胰腺癌的疗效。 Objective To investigate the binding characteristic of 18F-fluorodeoxyglucose( FDG) with human pancreatic carcinoma cell Patu 8988 and the effect of gemcitabine in the uptake of 18F-FDG on Patu 8988. Methods The binding efficiency of 18F-FDG was measured under different conditions: 5 × 104 ~ 1 × 107 cells; 1. 85 ~ 29. 6 kBq 18F-FDG; 0 ~ 11. 1mmol/L glucose levels; 20 ~ 120 min incubation in 37℃. The proliferation inhibition effect and the binding efficiency of 18F-FDG were detected at the 24th hour after administration of gemcitabine. Results The binding efficiency was ( 60. 60 ± 3. 05) % at the optimum binding condition of 1 × 106cells,3. 7kBq 18F-FDG,5. 55mmol/L glucose and 100min incu-bation at 37℃. The binding efficiency was ( 58. 35 ± 2. 19) % ,( 56. 34 ± 1. 56) % ,( 48. 92 ± 5. 91) % , ( 39. 14 ±7. 40) %,( 29. 67 ±4. 41) % at the 24th hour after administration of 0,5,20,40,60mmol/L gemcitabine. The binding efficiency was negatively correlated with the dose of gemcitabine ( r =-0. 928, P 0. 01) . The binding inhibition efficiency was positively correlated with the proliferation inhibition ( r = 0. 856,P 0. 01) . Conclusion The binding efficiency of 18F-FDG with human pancreatic carcinoma cell Patu 8988 decreased at the 24th hour after administration of gemcitabine.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2010年第5期1010-1013,1020,共5页 Suzhou University Journal of Medical Science
基金 卫生部核医学重点实验室开放课题(KF200904) 2008年度苏州大学附属第一医院联邦优秀中青年医师培养基金(LB0815)
关键词 胰腺癌 细胞结合率 吉西他滨 18F-氟代脱氧葡萄糖 疗效 pancreatic carcinoma binding efficiency gemcitabine 18F-FDG treatment efficacy
  • 相关文献

参考文献2

  • 1任瑞美,于金明,李文通,宋现让,杨国仁,孙新东,张建东.RNA干扰HIF-1α对人肺腺癌细胞SPCA-1摄取^(18)F-FDG的影响[J].中华核医学杂志,2005,25(3):161-163. 被引量:5
  • 2Ulrike Seitz,Martin Wagner,Bernd Neumaier,Edgar Wawra,Gerhard Glatting,Gerhard Leder,Roland M. Schmid,Sven N. Reske. Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3’-[18F]fluoro-3’-deoxythymidine ([18F]FLT) in pancreatic cancer cell lines[J] 2002,European Journal of Nuclear Medicine and Molecular Imaging(9):1174~1181

二级参考文献15

  • 1Semenza GL. Intratumoral hypoxia, radiation resistance, and HIF-1.Cancer Cell, 2004, 5:405-406.
  • 2Welsh S, Williams R, Kirkpatrick L, et al. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α. Mol Cancer Ther, 2004, 3: 233-244.
  • 3Rapisarda A, Shoemaker RH, Melillo G. Targeting topoisomerase Ⅰ to inhibit hypoxia inducible factor 1. Cell Cycle, 2004, 3: 172-175.
  • 4Stoeltzing O, McCarty MF, Wey JS, et al. Role of hypoxia-inducible factor 1α in gastric cancer cell growth, angiogenesis, and vessel maturation.J Natl Cancer Inst, 2004, 96: 946-956.
  • 5Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Ann Rev Cell Der Biol, 1999, 15: 551-578.
  • 6Hanze J, Eul BG, Savai R, et al. RNA interference for HIF-1α inhibits its downstream signalling and affects cellular proliferation. Biochem Biophys Res Commun, 2003, 312: 571-577.
  • 7Jung F, Haendeler J, Hoffmann J, et al. Hypoxic induction of the hypoxia-inducible factor is mediated via the adaptor protein Shc in endothelial cells. Circ Res, 2002, 91: 38-45.
  • 8Chen J, Zhan S, Nakada K, et al. Dominant-negative hypoxia-inducible factor-1α reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol, 2003, 162: 1283-1291.
  • 9Yen TC, See LC, Lai CH, et al. ^18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J Nucl Med, 2004, 45: 22-29.
  • 10Clavo AC, Brown RS, Wahl RL. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med, 1995, 36: 1625-1632.

共引文献4

同被引文献24

  • 1齐亚莉,张文英,张国宝,逮忠捍,张哲辉.女性乳腺癌危险因素Meta分析[J].中国肿瘤,2007,16(1):14-15. 被引量:17
  • 2Bosset JF,Collette L,Calais G,et al.Chemotherapy with preoperative radiotherapy in rectal cancer[J].N Engl J Med,2006,355(11):1114-1123.
  • 3Direcks WGE,Berndsen SC,Proost N,et al.18 F-FDG and 18 F-FLT uptake in human breast cancer cells in relation to the effects of chemotherapy:an in vitro study[J].Brit J Cancer,2008,99(3):481-487.
  • 4Pijl MEJ,Chaoui AS,Wahl RL,et al.Radiology of color-ectal cancer[J].Eur J Cancer,2002,38(7):887-898.
  • 5Pauwels EK,McCready VR,Stoot JH,et al.The mechanism of accumulation of tumour-localising radiopharmaceuticals[J].Eur J Nucl Med,1998,25(3):277-305.
  • 6Price P.PET as a potential tool for imaging molecular mechanisms of oncology in man[J].Trends Mol Med,2001,7(10):442-446.
  • 7Brown RS,Leung JY,Kison PV,et al.Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer[J].J Nucl Med,1999,40(4):556-565.
  • 8Clavo AC,Brown RS,Wahl RL.Fluorodeoxyglucose up-take in human cancer cell lines is increased by hypoxia[J].J Nucl Med,1995,36(9):1625-1632.
  • 9Arulampalam THA,Costa DC,Loizidou M.Positron emis-sion tomography and colorectal cancer[J].Brit J Surg,2001,88(2):176-189.
  • 10Burt BM,Hummy JL,Kooby DA,et al.Using positron e-mission tomography with 18 F-FDG to predict tumor behav-ior in experimental colorectal cancer[J].Neoplasia,2001,3(3):189-195.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部